Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein-enhanced small molecule disruptors of ordered membrane domains.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Combining automated patch clamp with optogenetics enables selective recording of DRG neurons subtypes.

bioRxiv : the preprint server for biology·2026
Same author

An upstream open reading frame represses translation of the neuronal potassium channel KCNQ2.

bioRxiv : the preprint server for biology·2026
Same author

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification.

medRxiv : the preprint server for health sciences·2026
Same author

High-throughput screening identifies a trafficking corrector for long QT syndrome-associated KCNQ1 variants.

JCI insight·2026
Same author

Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretation.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 30, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.

Eduardo Guadarrama1, Carlos G Vanoye1, Paul G DeCaen1,2

  • 1Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Biorxiv : the Preprint Server for Biology
|January 27, 2025
PubMed
Summary

Researchers identified potent PKD2L1 antagonists using high-throughput screening. This study defines novel drug targets for polycystin channels, advancing TRP channel research and potential therapeutics.

Keywords:
ADPKDComputational BiophysicsHigh-Throughput ElectrophysiologyMolecular DockingPKD2PKD2L1PharmacologyTRP channelsautosomal polycystic kidney diseaseion channelsmolecular mechanismspolycystinprimary cilia

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Experiment Videos

Last Updated: May 30, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.5K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Area of Science:

  • Ion channel pharmacology
  • Molecular neuropharmacology
  • Drug discovery

Background:

  • Polycystins (PKD2, PKD2L1) are TRP channels crucial for brain and kidney function, implicated in diseases like polycystic kidney disease and autism spectrum disorder.
  • Despite their importance, the polycystin pharmacophore remains undefined due to challenges in drug screening and unique subcellular localization.
  • PKD2L1 forms constitutively active plasma membrane channels when overexpressed, making it a target for pharmacological modulation.

Purpose of the Study:

  • To identify potent modulators of PKD2L1 ion channels.
  • To define the molecular interactions and binding sites of identified modulators.
  • To establish a framework for expanding chemical knowledge of polycystins.

Main Methods:

  • High-throughput electrophysiology screening of HEK293 cells expressing PKD2L1 F514A.
  • In-silico docking analysis and site-directed mutagenesis to identify receptor sites.
  • Assessment of binding site accessibility using membrane-impermeable QX-314.

Main Results:

  • Identification of potent PKD2L1 antagonists with diverse chemical structures.
  • Discovery of similarities between PKD2L1 and voltage-gated sodium channel pharmacology.
  • Localization of a novel, open-state accessible lateral fenestration receptor within the PKD2L1 pore.

Conclusions:

  • The developed screening approach is effective for polycystin drug discovery.
  • A mechanism of inhibition stabilizing the PKD2L1 inactivated state was elucidated.
  • Novel receptor moieties were identified for developing specific TRP channel antagonists.